Auxly Cannabis Group Stock Fundamentals
| CBWTF Stock | USD 0.03 0 3.70% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly OTC Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis otc stock.
Auxly |
Auxly Cannabis Group OTC Stock Operating Margin Analysis
Auxly Cannabis' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Auxly Cannabis Operating Margin | (0.52) % |
Most of Auxly Cannabis' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Auxly Cannabis Group has an Operating Margin of -0.5177%. This is 98.52% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is 90.6% lower than that of the firm.
Auxly Cannabis Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Auxly Cannabis's current stock value. Our valuation model uses many indicators to compare Auxly Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Auxly Cannabis competition to find correlations between indicators driving Auxly Cannabis's intrinsic value. More Info.Auxly Cannabis Group is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Auxly Cannabis' earnings, one of the primary drivers of an investment's value.Auxly Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auxly Cannabis' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics of similar companies.Auxly Cannabis is currently under evaluation in operating margin category among its peers.
Auxly Fundamentals
| Return On Equity | -0.81 | |||
| Return On Asset | -0.0868 | |||
| Profit Margin | (1.34) % | |||
| Operating Margin | (0.52) % | |||
| Current Valuation | 146.85 M | |||
| Shares Outstanding | 913.01 M | |||
| Shares Owned By Insiders | 21.04 % | |||
| Shares Owned By Institutions | 3.18 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 0.16 X | |||
| Revenue | 83.83 M | |||
| Gross Profit | 19.29 M | |||
| EBITDA | (18.3 M) | |||
| Net Income | (33.74 M) | |||
| Cash And Equivalents | 20.53 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 151.36 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 2.58 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (49.63 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 558 | |||
| Beta | 0.77 | |||
| Market Capitalization | 14.61 M | |||
| Total Asset | 450.42 M | |||
| Net Asset | 450.42 M |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada. Cannabis Wheaton operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 558 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Auxly OTC Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.